229 filings
Page 5 of 12
8-K
zhl4d6u
25 Feb 21
Regulation FD Disclosure
7:01am
CT ORDER
ou1j836ycetp go77ij
3 Feb 21
Confidential treatment order
12:00am
424B3
e4zclwrr vl94va7e7
27 Jan 21
Prospectus supplement
8:41am
8-K
c9q98zwx
20 Jan 21
Syros Announces Proposed Offering of Common Stock
4:04pm
424B5
2qvx 172906tztiglqj
20 Jan 21
Prospectus supplement for primary offering
4:02pm
EFFECT
gm2c8pc7ezp ny96
20 Jan 21
Notice of effectiveness
12:16am
424B5
sr7ls1g
19 Jan 21
Prospectus supplement for primary offering
4:06pm
8-K
q9t7v8q
19 Jan 21
Other Events
4:00pm
CORRESP
6b980 q6z
14 Jan 21
Correspondence with SEC
12:00am
UPLOAD
pyt2erq1px
13 Jan 21
Letter from SEC
12:00am
8-K
6e9hb 5x2r6f
11 Jan 21
Syros Announces Strategic Priorities and Expected Milestones
7:53am
8-K
eddci809do0fvc17cl
23 Dec 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:07pm
D
2kxt6
17 Dec 20
$121.61M in equity / options, sold $90.49M, 8 investors
4:21pm
8-K
73cixe
8 Dec 20
Syros Closes $90.5 Million Strategic Financing
4:44pm
8-K
is8vhdva utbjynu72
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
cnl3izum6fe
26 Oct 20
Syros Presents Initial Data from Phase 1 Clinical Trial of SY-5609, Its Selective Oral
6:10am
8-K
aupxlc
9 Sep 20
Departure of Directors or Certain Officers
8:30am